These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7784092)

  • 41. High prevalence of the C634Y mutation in the RET proto-oncogene in MEN 2A families in Spain.
    Sánchez B; Robledo M; Biarnes J; Sáez ME; Volpini V; Benítez J; Navarro E; Ruiz A; Antiñolo G; Borrego S
    J Med Genet; 1999 Jan; 36(1):68-70. PubMed ID: 9950371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. "Cold" single-strand conformational variants for mutation analysis of the RET protooncogene.
    Musholt PB; Musholt TJ; Goodfellow PJ; Zehnbauer BA; Wells SA; Moley JF
    Surgery; 1997 Aug; 122(2):363-70; discussion 370-1. PubMed ID: 9288142
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RET gene mutations and polymorphisms in medullary thyroid carcinomas in Indian patients.
    Sharma BP; Saranath D
    J Biosci; 2011 Sep; 36(4):603-11. PubMed ID: 21857107
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RET gene and its implications for cancer.
    Goodfellow PJ; Wells SA
    J Natl Cancer Inst; 1995 Oct; 87(20):1515-23. PubMed ID: 7563185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Germ line mutation analysis in families with multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma.
    Karga HJ; Karayianni MK; Linos DA; Tseleni SC; Karaiskos KD; Papapetrou PD
    Eur J Endocrinol; 1998 Oct; 139(4):410-5. PubMed ID: 9820617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium.
    Mulligan LM; Marsh DJ; Robinson BG; Schuffenecker I; Zedenius J; Lips CJ; Gagel RF; Takai SI; Noll WW; Fink M
    J Intern Med; 1995 Oct; 238(4):343-6. PubMed ID: 7595170
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutation of RET codon 768 is associated with the FMTC phenotype.
    Boccia LM; Green JS; Joyce C; Eng C; Taylor SA; Mulligan LM
    Clin Genet; 1997 Feb; 51(2):81-5. PubMed ID: 9111992
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid, nonradioactive screening for mutations in exons 10, 11, and 16 of the RET protooncogene associated with inherited medullary thyroid carcinoma.
    Siegelman M; Mohabeer A; Fahey TJ; Tomlinson G; Mayambala C; Jafari S; Noll WW; Thibodeau SN; Dawson DB
    Clin Chem; 1997 Mar; 43(3):453-7. PubMed ID: 9068588
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modification of multiple endocrine neoplasia 2A phenotype by cell membrane proximity of RET mutations in exon 10.
    Machens A; Hauptmann S; Dralle H
    Endocr Relat Cancer; 2009 Mar; 16(1):171-7. PubMed ID: 18936155
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC.
    Mulligan LM; Eng C; Healey CS; Clayton D; Kwok JB; Gardner E; Ponder MA; Frilling A; Jackson CE; Lehnert H
    Nat Genet; 1994 Jan; 6(1):70-4. PubMed ID: 7907913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Segregation of the V804L mutation and S836S polymorphism of exon 14 of the RET gene in an extended kindred with familial medullary thyroid cancer.
    Patócs A; Valkusz Z; Igaz P; Balogh K; Tóth M; Varga I; Rácz K
    Clin Genet; 2003 Mar; 63(3):219-23. PubMed ID: 12694233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RET proto-oncogene in Sardinia: V804M is the most frequent mutation and may be associated with FMTC/MEN-2A phenotype.
    Pinna G; Orgiana G; Riola A; Ghiani M; Lai ML; Carcassi C; Mariotti S
    Thyroid; 2007 Feb; 17(2):101-4. PubMed ID: 17316110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A complex nine base pair deletion in RET exon 11 common in sporadic medullary thyroid carcinoma.
    Alemi M; Lucas SD; Sällström JF; Bergholm U; Akerström G; Wilander E
    Oncogene; 1997 May; 14(17):2041-5. PubMed ID: 9160884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma.
    Eng C; Mulligan LM; Smith DP; Healey CS; Frilling A; Raue F; Neumann HP; Pfragner R; Behmel A; Lorenzo MJ
    Genes Chromosomes Cancer; 1995 Mar; 12(3):209-12. PubMed ID: 7536460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multigenerational familial medullary thyroid cancer (FMTC): evidence for FMTC phenocopies and association with papillary thyroid cancer.
    Fugazzola L; Cerutti N; Mannavola D; Ghilardi G; Alberti L; Romoli R; Beck-Peccoz P
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):53-63. PubMed ID: 11849247
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A RET double mutation in the germline of a kindred with FMTC.
    Bartsch DK; Hasse C; Schug C; Barth P; Rothmund M; Höppner W
    Exp Clin Endocrinol Diabetes; 2000; 108(2):128-32. PubMed ID: 10826520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical presentations and RET protooncogene mutations in seven multiple endocrine neoplasia type 2 kindreds.
    Blank RD; Sklar CA; Dimich AB; LaQuaglia MP; Brennan MF
    Cancer; 1996 Nov; 78(9):1996-2003. PubMed ID: 8909322
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Familial occurrence of thyroid tumors].
    Kameyama K; Takami H; Hosoda Y
    Nihon Rinsho; 1995 Nov; 53(11):2697-701. PubMed ID: 8538029
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Multiple endocrine neoplasia].
    Morimoto I
    Nihon Rinsho; 1995 Apr; 53(4):899-903. PubMed ID: 7752481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RET mutation Tyr791Phe: the genetic cause of different diseases derived from neural crest.
    Vaclavikova E; Dvorakova S; Sykorova V; Bilek R; Dvorakova K; Vlcek P; Skaba R; Zelinka T; Bendlova B
    Endocrine; 2009 Dec; 36(3):419-24. PubMed ID: 19826964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.